Embedding digital in Lilly’s portfolio

How Lilly is using digital technologies to improve patient outcomes

Eli Lilly and Co. is appointing leaders to drive its digital health agenda, with a strong focus on improving patient outcomes and reducing total healthcare costs.

Divakar Ramakrishnan, a 20-year veteran of Lilly, was named chief digital officer last June. His brief is to integrate digital tools across the therapeutic portfolio, which is consistent with Lilly’s move to start taking its product offerings beyond the pharmacotherapy to comprehensive solutions that extend to the healthcare system.

Ramakrishnan reports to Aarti Shah, who was named SVP, chief information and digital officer in January. Shah sits on the executive committee, and her remit is to oversee the integration of digital technologies throughout the company. Novartis AG, Pfizer Inc. and GlaxoSmithKline plc have chief digital officers on their executive committees, each with a similarly broad remit (see “A Year of Digital Progress at Novartis”).

On Feb. 12,

Read the full 1428 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE